(Q54509279)

English

Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Noel Jean Milpied

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Ibrahim Yakoub-Agha

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

P Chevallier

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

M Labopin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

K Bilger

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

G Socié

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

M Michallet

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

C-E Bulabois

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

S Maury

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Y Beguin

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

J-O Bay

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

D Blaise

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

N Maillard

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

G Guillerm

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

E Daguindeau

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

N Raus

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

M Mohty

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

0 references

publication date

2 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

361-365

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Allogeneic hematopoietic cell transplantation: the state of the art

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

The EBMT activity survey: 1990-2010

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Who is fit for allogeneic transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

A Proportional Hazards Model for the Subdistribution of a Competing Risk

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Allogeneic SCT in refractory or relapsed adult ALL is effective without prior reinduction chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Optimizing the conditioning regimen for allogeneic stem-cell transplantation in acute myeloid leukemia; dose intensity is still in need

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33(+) primary resistant or relapsed acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.186

21 January 2018

Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Tra

1 reference

https://pubmed.ncbi.nlm.nih.gov/24292522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Reg

1 reference

https://pubmed.ncbi.nlm.nih.gov/24292522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azacitidine after allo-SCT: the good without the bad?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24292522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic stem cell transplantation: a review and recommendations for follow-up care for the general practitioner.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24292522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://pubmed.ncbi.nlm.nih.gov/24292522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24292522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/24292522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24292522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24292522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24292522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BMT.2013.186

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292522%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54509279&oldid=2212494596"